fbpx
Colombia medical cannabis industry to see new opportunities

Colombia medical cannabis industry to see new opportunities

Colombia medical cannabis production has begun thanks to new laws passed in July

Although marijuana cultivation has been legal since late 2016, for the past five years Colombian companies could only export active pharmaceutical ingredients (APIs) and therefore were banned from the most lucrative parts of the business.

In July, Colombian president Ivan Duque loosened regulations to allow the export of dry cannabis flowers, which accounts for more than 50% of the demand in markets like the US.

Thanks to that policy change, Colombian companies are now confident they can compete in the pharmaceutical markets in Europe and North America.

Favorable conditions

The Andean nation enjoys perfect conditions for the cultivation of marijuana: 12 hours of sunlight give way to 12 hours of darkness virtually every day of the year, with minimal seasonal change.

High altitude — Clever Leaves’ farm, in Boyacá, sits at 9,377 feet above sea level — means fewer pesticides are required to stem bacteria and disease than at lower altitudes, making it easier to grow organic products.

“If you think about it, greenhouses in other countries are trying to emulate the natural conditions we get here for free,” Clever Leaves’ president Andres Fajardo told CNN. “Your factor costs in terms of labor are significantly cheaper.”

Investment in Colombian medical marijuana has picked up, with the government reporting more than $250 million in foreign funding in the sector. The majority of those dollars come from international cannabis companies, mostly Canadian, that are partnering with Colombian producers to farm there.

Flora Growth, a Toronto-based firm listed on NASDAQ, has purchased 100 hectares of land — about 247 acres — in central Colombia. “I hope that over the next three-to-five years we are going to run out of land,” said Luis Merchán, a Colombian businessman who quit his job as a VP at Macy’s to become Flora’s CEO last year.

Flora estimates its production costs to be around $.06 per gram of dry cannabis flower, a fraction of the go-to price that ranges from $.50 cents and $2 in the US.

Licenses here are also much cheaper than abroad, we are talking of $15,000 to $20,000 per license,” said Juliana Salazar, a private consultant involved in the Bogota cannabis industry. “And an initial investment of roughly $100,000 to start producing here, which is a lot of money in Colombia, but a smaller investment than if you look at Germany, Spain or the United States.”

Washington DC Marijuana Laws Could Be Changing

Washington DC Marijuana Laws Could Be Changing

If the current Washington DC marijuana laws confuse you, you aren’t alone.

If you went to Washington DC today in search of cannabis, you might struggle to find it. Despite Washington DC marijuana laws allowing the possession, cultivation and consumption of cannabis for recreational use, there isn’t a single retail recreational cannabis store where you can legally purchase cannabis.

Cannabis is still attainable in DC just like most places in the country without legal access to cannabis, but the methods can vary with different levels of success.

Washington DC Marijuana Laws

Washington DC legalized cannabis nearly seven years ago in February 2015. While the legislature legalized everything necessary to begin the process of opening up a retail cannabis industry, there was one major roadblock.

Rep. Andy Harris, a Republican, included a rider in the bill that including language preventing DC from implementing any sort of recreational cannabis industry, by not permitting district funds to be used for the process. In other words, Washington DC is unable to have a recreational cannabis industry because they are currently not allowed to fund a regulatory commission, establish licensing processes and design a regulated industry framework.

So while Washington DC marijuana laws resemble that of every other state that has legalized cannabis, there is still no legal industry. With all that said, finding weed in DC is relatively easy these days thanks to a thriving grey market.

The law in DC permits any one person to give any cannabis they have or have grown to any other person as long as they do not charge for it, as selling cannabis is currently illegal under the rider. This has led to the creation of a gift/donation system that has helped bloom a massive underground industry in DC.

This can work in various ways; from “donating” $40 for a T-shirt in a hydroponic store and being “gifted” a few grams of cannabis, to full-blown delivery services where you donate for a single sticker (that happens to cost about $200) in exchange for a gift box with cannabis flower, edibles and cartridges. Unfortunately for the consumer, this market is still completely unregulated since it is being done through a loophole in the bill’s language.

Consumers constantly run the risk of over paying for low quality cannabis from a shady shop or service, and there are so many different delivery services, finding one that doesn’t rip you off can be a real challenge. But that could be changing thanks to a new adjustment to the Senate budget proposal for 2022.

Washington DC could have legal cannabis for sale soon

Washington DC marijuana laws are particularly complicated due to the nature of Washington DC itself. It is considered the Capitol of the country, but it is not actually a state or a city, and its Mayor is also the Governor, among other peculiarities. Due to the nature of how DC works, it creates complications when the district has differing opinions on legislation compared to the federal government that is housed there.

When Joe Biden released his 2022 budget proposal it still included the Harris Rider, leaving many advocates disappointed. The Democrat president has expressed consistent opposition to cannabis legalization on the federal level. However the House voted to remove the rider back in June, and now the Senate Appropriations Committee seems to be moving that sentiment forward.

In a new text of legislation released by Committee Chairman Patrick Leahy, a budget proposal to fund the federal government for Fiscal Year 2022 is presented, which among other measures, purposely fails to include the Harris Rider.

The legislation also contains several other cannabis provisions, including to continue an existing protection for state medical marijuana laws, call on the federal government to reconsider policies that fire employees for cannabis, criticize the restrictive drug classification system that impedes scientific research and encourage the development of technologies to detect THC-impaired driving.

It is very common for legislators to attempt and slide in additional changes to legislation in most cases, but also regarding cannabis. Some advocates blame this practice for why a lot of cannabis legislation does not pass, saying that if legislators focused on one issue at a time that has more broad support, they would see more success.

A long fight may be ending

It is too soon to say if the final Budget Proposal will be approved, and more changes could occur before it is. The fight to change Washington DC marijuana laws has been long and fraught with disappointment.

The latest proposal appears to be a large step in the right direction, with House and Senate support for removing the rider. The 2022 Budget Proposal has a deadline of December 3rd, with Democrats eager to get everything finalized before then. However it is still unclear whether the spending panel or full Senate will take up the new revised proposal before then.

Yet again, the further progress of cannabis legalization depends on the slow moving legislature, notorious for “extending” deadlines as an excuse for just missing them. Only time will tell the future of cannabis legalization in Washington DC now.

Three in four California cannabis companies aren’t licensed

Three in four California cannabis companies aren’t licensed

Only 1 in 4 California cannabis companies have a permanent business license

State will give 17 cities and counties grants to help license cannabis businesses. But many say bigger problems remain.

Nearly four years after California started regulating its cannabis industry, three in four businesses still operate on provisional licenses.

As temporary license holders, 75% of the state’s cannabis industry lacks protections and privileges that come with holding full licenses — a situation that worries some in the business. Those temporary operators also haven’t passed extensive environmental reviews required of full licensing — a fact that concerns environmental groups.

Cannabis licensing is slow for a number of reasons, ranging from the sometimes dizzying complexity of California’s environmental rules to conflicting language between state and local cannabis laws to the high costs for permits and a shortage of government workers needed to process the paperwork.

The weed licensing glitch also isn’t new. For several years, state legislators have extended the permitting process so that thousands of businesses don’t become unlicensed overnight.

But now, California is pushing to change the situation. The state has set aside $100 million to help 17 cities and counties transition their cannabis businesses from temporary to full licensees. Los Angeles is eligible for $22.3 million of that money, while five other Southern California cities — Long Beach, San Diego, Commerce, Adelanto and Desert Hot Springs — are in the running for a combined $6.9 million. Applications are due by Nov. 15.

Eligible cities say they’ll use the money to hire staff and, in some cases, to offer direct support to businesses. They’re confident that over the next few months they can make a significant dent in the problem.

“I know it will help,” said Edgar Cisneros, city manager for Commerce, which has seven fully licensed cannabis businesses and 12 others waiting to get through the process.

“There is a real need for staff and also consultants…  to get these permits to permanent licensing at a much faster pace.”

Still, while business owners and others applaud the one-time state funding, they say it doesn’t go far enough. Many cities and counties remain left out of the applicant pool, and there is no statewide plan to ease the business hurdles that caused the backlog in the first place.

 

“No amount of money is going to change the significant amount of time it takes to come up to speed for local approval,” said Hilary Bricken, a cannabis industry attorney out of Los Angeles who said some businesses have failed during the multi-year wait to get licensed.

Nevada cannabis sales break $1 billion in 2021

Nevada cannabis sales break $1 billion in 2021

Nevada cannabis sales broke a record in 2021

Nevada retailers sold more than $1 billion in medical and recreational marijuana over a one-year period, state officials announced on Wednesday.

The Nevada Cannabis Compliance Board (CCB) and the Nevada Department of Taxation released the data, which shows $1,003,467,655 in taxable cannabis purchases in Fiscal Year 2021, which ran from July 1, 2020 to June 30, 2021.

By contrast, total marijuana sales for the prior 2020 fiscal year amounted to $685 million.

The bulk of the marijuana purchases ($791,100,017) came from Clark County, where Las Vegas is located. Another $135,326,790 of cannabis was sold in Washoe County, with Reno being the major city in that jurisdiction. The $77,040,859 remainder came from other counties.

Ten percent of tax revenue from recreational cannabis sales will support pubic education funding, as prescribed under a bill that Gov. Steve Sisolak (D) previously signed.

“This is what Nevadans expected since the legalization of recreational marijuana,” the governor said in a press release about the new sales data. “Education remains one of my top priorities, and I’m proud to see promised tax revenue from cannabis sales directly funding our students and classrooms.”

Sisolak also signed a bill in June to legalize marijuana consumption lounges in the state.

The new social use license types statewide and giving consumers this option—especially in the tourist-centric state—could further boost marijuana and other tax revenues.

The governor has also committed to promoting equity and justice in the state’s marijuana law. Last year, for example, he pardoned more than 15,000 people who were convicted for low-level cannabis possession.

That action was made possible under a resolution the governor introduced that was unanimously approved by the state’s Board of Pardons Commissioners.

Canopy Growth Pays Nearly $300 Million To Acquire Wana Edibles in the U.S.

Canopy Growth Pays Nearly $300 Million To Acquire Wana Edibles in the U.S.

canopy growth buys wana edibles brand

Canadian cannabis giant Canopy Growth is (kind of) acquiring Wana Brands, the #1 cannabis edibles brand in North America by market share – per Headset data.

According to information procured exclusively ahead of an official announcement, the deal features a similar structure to the one Canopy struck with Acreage Holdings a couple of years ago. Under the agreement, the Canadian operator will acquire the right to purchase Wana (comprised of Mountain High Products, Wana Wellness and The Cima Group) once THC becomes federally legal in the U.S.

The call option to acquire 100% of the membership interests in each Wana entity is being acquired by Canopy for upfront cash payment of $297.5 million.

When Canopy decides to move forward with the acquisition, it will pay 15% of the fair market value of the entities being acquired. Until the purchase is complete, thought Canopy Growth will have no economic, voting or controlling interest in Wana, which will continue to operate independently.

“Through the agreement with Wana, Canopy is adding another industry leading brand to power our rapid growth across the U.S. Wana has built a successful business using an asset-light licensing model, allowing them to scale across North America,” David Klein, CEO of Canopy Growth, said in an exclusive interview.

Breaking down the key strategic benefits of the acquisition, Klein explained Wana:

  • Strengthens Canopy Growth’s U.S. ecosystem.
  • Provides exposure to one of the fastest growing segments in both the U.S. and Canadian cannabis markets: edibles.
  • Would automatically make Canopy a leader in the edibles category.
  • Increases Canopy’s exposure to the U.S. market upon federal legalization.
  • Represents an opportunity to acquire a profitable and highly scalable business.
Billionaire-backed Denver Ordinance 300 would raise retail cannabis tax by 13%

Billionaire-backed Denver Ordinance 300 would raise retail cannabis tax by 13%

Denver Ordinance 300 would raise taxes on recreational cannabis.

An advocacy organization registered in Delaware and backed by a Bahamas-based billionaire Forbes calls “the world’s richest 29-year-old” is going head-to-head with the Denver cannabis industry — and the mayor — through a proposed city ordinance that would increase Denver’s recreational marijuana tax by 13%.

Initiated Ordinance 300, which will appear on the 2021 ballot, proposes that “Denver retail marijuana sales tax be increased by $7 million” through a 1.5% tariff to fund “pandemic research” at the University of Colorado Denver.

Should a statewide ballot initiative that will also be put before voters in 2021, Proposition 119, pass along with Ordinance 300, Denver cannabis consumers will be paying nearly 25% more for their weed within the next three years. Denver residents currently pay a total of 26.41% in taxes on recreational cannabis: 11.41% to the city and 15% to the state.

The move has Colorado cannabis industry insiders wondering why Colorado, why CU Denver and why their sector.

“Ordinance 300 taxes Denver cannabis consumers to fund, and I’m putting this in big old air quotes, ‘future pandemic research,'” Marijuana Industry Group Executive Director Truman Bradley told Denver Business Journal. “I literally cannot think of a cause that’s going to achieve more attention globally than [pandemic research]. It makes no sense to ask Denver cannabis consumers to foot the bill for that.”

MIG, along with industry advocacy organization Colorado Leads, primarily expressed concern about the impact on cannabis buyers who consume for medical purposes but may not have the means for a medical card — something that requires an often expensive annual physical exam and fees paid to the state — or simply don’t want to be on an official list.

“This measure — funded by a rich, out-of-town carpetbagger — taxes people’s pain relief to pay for a random pandemic preparation program that has no accountability, no oversight, no specific solutions and no connection to the marijuana industry,” Chuck Smith, Colorado Leads board president and CEO of Denver-based cannabis giant BellRock Brands, told DBJ. “If, as the proponents contend, this program is so beneficial, why aren’t all Denver industries asked to pay their fair share?”